Evidence map›Paper›PMID 42258544›Full record

ArticleNucleic acids research2026

Inducible CRISPRi enables efficient and high-fidelity genome editing in Streptomyces.

Chaoxian Bai, Hua Zhu, Lina M Bayona, Chao Du, Gilles P van Wezel

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chaoxian BaiInstitute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Hua ZhuInstitute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Lina M BayonaInstitute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Chao DuInstitute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.ORCID 0000-0003-3447-5293
Gilles P van WezelInstitute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.ORCID 0000-0003-0341-1561

Funding

China Scholarship Council 101055020European Research Council
6 · The paper itself

Abstract

Streptomycetes are prolific producers of bioactive natural products, but many of the biosynthetic gene clusters (BGCs) are silent in the laboratory. Genetic manipulation is important to unlock their full potential. CRISPR-Cas-based genome editing has greatly advanced genetic engineering in Streptomyces. However, several challenges remain, including Cas nuclease toxicity, unintended genomic rearrangements, and elimination of the delivery plasmid. Here, we present a novel genome editing strategy that harnesses cumate-inducible CRISPR interference (CRISPRi) to transiently knockdown essential genes such as divIVA or dnaA as counterselectable marker. This enforces loss of the vector backbone, promotes homologous recombination, and yields markerless mutants by loss of the antibiotic resistance cassette during the final recombination step. We demonstrate the versatility of the ICE system (Inducible CRISPRi targeting an Essential gene) by (i) deleting four BGCs in Streptomyces coelicolor M145, (ii) inserting both a promoter and a large BGC, and (iii) introducing precise single-nucleotide substitutions. Furthermore, deletion of the prodigiosin BGC elicited expression of a poorly expressed BGC for prolinolexin lipopeptides in Streptomyces roseifaciens DSM 106196T. Considering that different essential genes may be targeted, we anticipate that inducible CRISPRi-based counterselection may be adaptable to genome editing strategies in a broad range of microbial systems.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsGenome, BacterialStreptomycesStreptomyces coelicolorGene Knockdown TechniquesGenes, EssentialHomologous RecombinationMultigene Family

Identifiers

PMID42258544
PMCPMC13244146

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.